Protocol No.: EA4151
- Title
- A Randomized Phase III Trial of Consolidation with Autologous Hematopoietic Cell Transplantation Followed by Maintenance Rituximab vs. Maintenance Rituximab Alone for Patients with Mantle Cell Lymphoma In Minimal Residual Disease-Negative First Complete Remission
- Principal Investigator
- Veltri, Lauren
- Phase
- III
- Age Group
- Adult
- Applicable Disease Site
- Lymphoma
- Participating Institutions
- Camden Clark Medical Center
- Mary Babb Randolph Cancer Center
- Contacts
- Kristin Volk, RN
- Research Nurse
- Phone: +1 304-581-1893
- Email: kristin.volk@hsc.wvu.edu
- Layla Tannoury
- Clinical Research Specialist
- Phone: +1 304-424-2585
- Email: layla.tannoury@wvumedicine.org